What to monitor: The same factors as the 1 mg phase, plus blood glucose patterns if you monitor them, hydration status (GLP-1 agonists can reduce thirst cues), and mood or energy shifts that may indicate metabolic transition
Evidence from TRIUMPH-4 and TRIUMPH-1: Mostly rated as "mild" by participants Rarely led to discontinuation (12%) No progression to serious neurological issues Reversible when medication stopped (in Phase 2 extension) When to Call Your Doctor About Dysesthesia Call if you experience: Severe pain (not just tingling) Progressive worsening despite dose stability Loss of coordination or balance Weakness in hands or feet Symptoms interfering with daily life Likely benign if: Mild tingling only Stable or improving over time No pain or weakness Managing Nausea: The Most Common Side Effect Why GLP-1 Medications Cause Nausea GLP-1 slows gastric emptying food stays in stomach longer Longer gastric residence feeling of fullness (desired!) or nausea (not desired) Brain signaling changes nausea sensation Good news: This is the SAME mechanism producing weight loss
Phase 2 Type 2 Diabetes Trial: Rosenstock J, Frias J, Jastreboff AM, et al
Results You Can Trust Our medical team helps you maintain your results through nutrition and lifestyle guidance
Patients looking for doctor supervised weight loss Chicago care should prioritize that over hype
For most adults over 40, the practical question is not just about biological optimization it is about minimizing disruption to work performance, sleep quality, and training schedule during the higher-symptom window post-injection
.webp)
